ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.

https://repo.qst.go.jp/records/74737
https://repo.qst.go.jp/records/74737
400f48bd-1f99-4381-a35b-49d6ec6e247b
Item type 学術雑誌論文 / Journal Article(1)
公開日 2019-03-15
タイトル
タイトル Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Effendi, Nurmaya

× Effendi, Nurmaya

WEKO 869625

Effendi, Nurmaya

Search repository
Mishiro, Kenji

× Mishiro, Kenji

WEKO 869626

Mishiro, Kenji

Search repository
Takarada, Takeshi

× Takarada, Takeshi

WEKO 869627

Takarada, Takeshi

Search repository
Nishii, Ryuichi

× Nishii, Ryuichi

WEKO 869628

Nishii, Ryuichi

Search repository
Yamada, Daisuke

× Yamada, Daisuke

WEKO 869629

Yamada, Daisuke

Search repository
Shiba, Kazuhiro

× Shiba, Kazuhiro

WEKO 869630

Shiba, Kazuhiro

Search repository
Kinuya, Seigo

× Kinuya, Seigo

WEKO 869631

Kinuya, Seigo

Search repository
Odani, Akira

× Odani, Akira

WEKO 869632

Odani, Akira

Search repository
Ogawa, Kazuma

× Ogawa, Kazuma

WEKO 869633

Ogawa, Kazuma

Search repository
Nishii, Ryuichi

× Nishii, Ryuichi

WEKO 869634

en Nishii, Ryuichi

Search repository
抄録
内容記述タイプ Abstract
内容記述 Several malignant tumors and fibrotic diseases are associated with PDGFRβ overexpression and excessive signaling, making this receptor attractive for molecular targeting and imaging approaches. A series of benzo[d]imidazole-quinoline derivatives were designed and synthesized to develop radioiodinated compounds as PDGFRβ-specific imaging probes. The structure activity relationship (SAR) evaluation of the designed compounds was performed. Among them, 2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]-8-(piperazin-1-yl)quinoline (5a) and 4-{2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}morpholine (5d) exhibited a relatively high PDGFRβ-TK inhibitory potency, whereas iodinated 5a derivative 5-iodo-2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]-8-(piperazin-1-yl)quinoline (8) exhibited a superior inhibitory potency as PDGFRβ inhibitor than iodinated 5d derivative 4-{5-iodo-2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}morpholine (11). Furthermore, [I]8 and [I]11 were synthesized and evaluated for PDGFRβ radioligand ability, both in vitro and in vivo. Cellular uptake experiments showed that [I]8 had a higher uptake in BxPC3-luc cells as PDGFRβ-positive cells than [I]11. Incubation of [I]8 after pretreatment of PDGFRβ ligands significantly reduced the uptake of [I]8. In biodistribution experiments using tumor-bearing mice, [I]8 accumulation in the tumor 1 h postinjection was higher than that of the benzo[d]imidazol-quinoline derivative [I]IIQP, used in our previous research. These results indicate that [I]8 could be a promising PDGFRβ imaging agent. Although its clinical application requires further structural modifications, the results obtained in this research may be useful for the development of PDGFRβ-specific radioligands.
書誌情報 Bioorganic & medicinal chemistry

巻 27, 号 2, p. 383-393, 発行日 2019-01
出版者
出版者 Elsevier
ISSN
収録物識別子タイプ ISSN
収録物識別子 0968-0896
PubMed番号
識別子タイプ PMID
関連識別子 30563725
DOI
識別子タイプ DOI
関連識別子 10.1016/j.bmc.2018.12.016
関連サイト
識別子タイプ URI
関連識別子 https://www.sciencedirect.com/science/article/pii/S0968089618315414
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 18:07:14.846374
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3